
Carolina Del Socorro Solis-Herrera MD
Diabetes, Lipid Metabolism
Physician
Join to View Full Profile
8300 Floyd Curl DrFl 3San Antonio, TX 78229
Phone+1 210-450-9490
Fax+1 210-450-2103
Dr. Solis-Herrera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Endocrinology, Diabetes, and Metabolism, 2017
Texas Tech University (Permian Basin)Residency, Internal Medicine, 2013 - 2016
Autonomous University of Baja California School of MedicineClass of 2003
Certifications & Licensure
TX State Medical License 2017 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
American Board of Obesity Medicine Obesity Medicine
Clinical Trials
- SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan Start of enrollment: 2021 Jan 13
Roles: Principal Investigator, Contact
- SGLT2 Inhibition in Older Obese Adults With Pre-diabetes Start of enrollment: 2020 Jun 25
Roles: Principal Investigator, Contact
- Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1 Start of enrollment: 2019 Jan 07
Roles: Contact
Publications & Presentations
PubMed
- Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of the CONFIDENCE Randomized Trial.Rajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, Janet B McGill, Amy Mottl
Journal of the American College of Cardiology. 2025-11-07 - 2 citationsPost Hoc Analyses of DKD Clinical Trials in Ethnic Minorities (Asian, Hispanic, Black) Narrative Review.Li-Li Hsiao, Steven G Coca, Samuel H Fantaye, Francisca M Acosta, Carolina Solis-Herrera
Clinical Therapeutics. 2025-11-01 - Repeated Withdrawal of a GLPR Agonist Induces Hyperleptinemia and Deteriorates Metabolic Health in Obese Aging UM-HET3 Mice.Nisi Jiang, Jiyuan Yin, Noah Lawrence, Jieyi Meng, Laurence T Maeyens
Aging Cell. 2025-10-01
Press Mentions
San Antonio Doctors Hosting Free Health Clinic for World Obesity Day on TuesdayMarch 4th, 2025
Diabetes Alert Day's Wake-up Call to a Deadly DiseaseMarch 28th, 2023
Local Endocrinologist Explains Growing Evidence of Troubling Link Between COVID-19 and DiabetesNovember 12th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









